Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Soldan

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Sexually Transmitted Infections|December 17, 2014
Confirmatory assays are essential when using molecular testing for Neisseria gonorrhoeae in low-prevalence settings: insights from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)Nigel Field, Soazig Clifton, Sarah Alexander, et al.
International Journal of Epidemiology|November 5, 2015
Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)Pam Sonnenberg, Catherine A Ison, Soazig Clifton, et al.
Vaccine|April 21, 2012
Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisationRebecca Howell-Jones, Natasha de Silva, Mercy Akpan, et al.
Health Technology Assessment (Winchester, England)|September 25, 2020
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCTRichard Gilson, Diarmuid Nugent, Kate Bennett, et al.
Sexually Transmitted Infections|August 21, 2015
Is chlamydia screening and testing in Britain reaching young adults at risk of infection? Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)Sarah C Woodhall, Kate Soldan, Pam Sonnenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2015
High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability SurveyClare Tanton, Kate Soldan, Simon Beddows, et al.
Lancet (London, England)|November 30, 2013
Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)Pam Sonnenberg, Soazig Clifton, Simon Beddows, et al.
Transfusion Medicine Reviews|September 30, 2006
Serious hazards of transfusion: a decade of hemovigilance in the UKDorothy Stainsby, Hilary Jones, Deborah Asher, et al.
Emerging Infectious Diseases|September 21, 2016
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine GenotypesDavid Mesher, Kate Soldan, Matti Lehtinen, et al.
The Lancet. Infectious Diseases|March 7, 2015
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisMélanie Drolet, Élodie Bénard, Marie-Claude Boily, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Sexually Transmitted Infections|December 17, 2014
Confirmatory assays are essential when using molecular testing for Neisseria gonorrhoeae in low-prevalence settings: insights from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)Nigel Field, Soazig Clifton, Sarah Alexander, et al.
International Journal of Epidemiology|November 5, 2015
Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)Pam Sonnenberg, Catherine A Ison, Soazig Clifton, et al.
Vaccine|April 21, 2012
Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisationRebecca Howell-Jones, Natasha de Silva, Mercy Akpan, et al.
Health Technology Assessment (Winchester, England)|September 25, 2020
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCTRichard Gilson, Diarmuid Nugent, Kate Bennett, et al.
Sexually Transmitted Infections|August 21, 2015
Is chlamydia screening and testing in Britain reaching young adults at risk of infection? Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)Sarah C Woodhall, Kate Soldan, Pam Sonnenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2015
High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability SurveyClare Tanton, Kate Soldan, Simon Beddows, et al.
Lancet (London, England)|November 30, 2013
Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)Pam Sonnenberg, Soazig Clifton, Simon Beddows, et al.
Transfusion Medicine Reviews|September 30, 2006
Serious hazards of transfusion: a decade of hemovigilance in the UKDorothy Stainsby, Hilary Jones, Deborah Asher, et al.
Emerging Infectious Diseases|September 21, 2016
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine GenotypesDavid Mesher, Kate Soldan, Matti Lehtinen, et al.
The Lancet. Infectious Diseases|March 7, 2015
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisMélanie Drolet, Élodie Bénard, Marie-Claude Boily, et al.
Pageof 7